Huiping Guo
- Pharmacology top 10%
-
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 4
- Renal and related cancers 3
- TGF-β signaling in diseases 2
- Congenital heart defects research 2
-
- Renal cell carcinoma treatment 3
-
- MRI in cancer diagnosis 2
-
- Estrogen and related hormone effects 2
- Co-authors
- Jinyi ShaoBret M. EversHongmiao ShengSean Bong LeeWei XiaoChristopher G. WoodErica CampagnaroTapati Maity
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Huiping Guo
21 papers receiving 472 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 87
- Pharmacology 94
- Molecular Biology 320
- Oncology 118
- Immunology and Allergy 14
Countries citing papers authored by Huiping Guo
This map shows the geographic impact of Huiping Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiping Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiping Guo more than expected).
Fields of papers citing papers by Huiping Guo
This network shows the impact of papers produced by Huiping Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiping Guo. The network helps show where Huiping Guo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huiping Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 6 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 3 | |
| 9 | 2020 | 5 | |
| 10 | miR-424-5p Promotes Proliferation, Migration and Invasion of Laryngeal Squamous Cell Carcinoma | 2019 | 3 |
| 11 | 2019 | 20 | |
| 12 | Comparison Of Three Different Treatment Methods For Cesarean Scar Pregnancy | 2019 | 1 |
| 13 | 2019 | 10 | |
| 14 | 2017 | 9 | |
| 15 | 2016 | 17 | |
| 16 | 2016 | 11 | |
| 17 | 2015 | 6 | |
| 18 | 2010 | 37 | |
| 19 | 2003 | 65 | |
| 20 | 2003 | 92 |
About Huiping Guo
Huiping Guo is a scholar working on Physiology, Molecular Biology and Critical Care and Intensive Care Medicine, having authored 22 papers that have together received 480 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (4 papers), Renal cell carcinoma treatment (3 papers), Renal and related cancers (3 papers), MRI in cancer diagnosis (2 papers), TGF-β signaling in diseases (2 papers), Congenital heart defects research (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Cancer Research (87 citations), Pharmacology (94 citations) and Molecular Biology (320 citations). Huiping Guo has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jinyi Shao, Bret M. Evers, Hongmiao Sheng, Sean Bong Lee, Wei Xiao, Christopher G. Wood, Erica Campagnaro, Tapati Maity, Shauna N. LeGrand and Pheroze Tamboli. Their work appears in journals such as Frontiers in Plant Science, Stem Cells, Cell Death Discovery, Scientific Reports and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.